User profiles for Pawel Krawczyk
Pawel S KrawczykInternational Institute of Molecular and Cell Biology in Warsaw Verified email at iimcb.gov.pl Cited by 1099 |
PlasFlow: predicting plasmid sequences in metagenomic data using genome signatures
PS Krawczyk, L Lipinski… - Nucleic acids research, 2018 - academic.oup.com
Plasmids are mobile genetics elements that play an important role in the environmental
adaptation of microorganisms. Although plasmids are usually analyzed in cultured …
adaptation of microorganisms. Although plasmids are usually analyzed in cultured …
[HTML][HTML] Beyond PD-L1 markers for lung cancer immunotherapy
K Wojas-Krawczyk, E Kalinka, A Grenda… - International journal of …, 2019 - mdpi.com
Immunotherapy using immune checkpoints inhibitors has become the standard treatment for
first and second line therapy in patients with non-small cell lung cancer (NSCLC). However, …
first and second line therapy in patients with non-small cell lung cancer (NSCLC). However, …
[HTML][HTML] Global view on the metabolism of RNA poly(A) tails in yeast Saccharomyces cerevisiae
A Tudek, PS Krawczyk, S Mroczek, R Tomecki… - Nature …, 2021 - nature.com
The polyadenosine tail (poly[A]-tail) is a universal modification of eukaryotic messenger
RNAs (mRNAs) and non-coding RNAs (ncRNAs). In budding yeast, Pap1-synthesized mRNA …
RNAs (mRNAs) and non-coding RNAs (ncRNAs). In budding yeast, Pap1-synthesized mRNA …
[HTML][HTML] Tumor Microenvironment—A short review of cellular and Interaction Diversity
A Bożyk, K Wojas-Krawczyk, P Krawczyk, J Milanowski - Biology, 2022 - mdpi.com
Simple Summary Scientists around the world have long been interested in understanding the
biology of cancer. Numerous studies that have been carried out so far clearly show that the …
biology of cancer. Numerous studies that have been carried out so far clearly show that the …
[HTML][HTML] Diet, microbiome, and cancer immunotherapy—A comprehensive review
…, P Bitkowska, P Chunowski, P Czuchryta, P Krawczyk… - Nutrients, 2021 - mdpi.com
The immune system plays a key role in cancer suppression. Immunotherapy is widely used
as a treatment method in patients with various types of cancer. Immune checkpoint blockade …
as a treatment method in patients with various types of cancer. Immune checkpoint blockade …
[HTML][HTML] Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report
T Powrózek, P Krawczyk, T Kucharczyk, J Milanowski - Medical oncology, 2014 - Springer
Currently, there are no sensitive diagnostic tests that could allow early detection of lung
cancer. Among some cancer patients, epigenetic changes in the nature of methylation of …
cancer. Among some cancer patients, epigenetic changes in the nature of methylation of …
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs
The exosome-independent exoribonuclease DIS3L2 is mutated in Perlman syndrome. Here,
we used extensive global transcriptomic and targeted biochemical analyses to identify …
we used extensive global transcriptomic and targeted biochemical analyses to identify …
[PDF][PDF] Uridylation by TUT4/7 restricts retrotransposition of human LINE-1s
Z Warkocki, PS Krawczyk, D Adamska, K Bijata… - Cell, 2018 - cell.com
LINE-1 retrotransposition is tightly restricted by layers of regulatory control, with epigenetic
pathways being the best characterized. Looking at post-transcriptional regulation, we now …
pathways being the best characterized. Looking at post-transcriptional regulation, we now …
Measuring the tail: Methods for poly (A) tail profiling
A Brouze, PS Krawczyk… - Wiley Interdisciplinary …, 2023 - Wiley Online Library
The 3′‐end poly(A) tail is an important and potent feature of most mRNA molecules that
affects mRNA fate and translation efficiency. Polyadenylation is a posttranscriptional process …
affects mRNA fate and translation efficiency. Polyadenylation is a posttranscriptional process …
[HTML][HTML] The role of intratumor heterogeneity in the response of metastatic non-small cell lung cancer to immune checkpoint inhibitors
M Nicoś, P Krawczyk, N Crosetto… - Frontiers in Oncology, 2020 - frontiersin.org
Immune checkpoint inhibitors (ICIs) represent one of the most promising therapeutic approaches
in metastatic non-small cell lung cancer (M-NSCLC). Unfortunately, approximately 50–…
in metastatic non-small cell lung cancer (M-NSCLC). Unfortunately, approximately 50–…